ISPE Publishes ISPE GAMP® RDI Good Practice Guide: Data Integrity by Design
This Guide was written by a group of experts and reviewed by regulators and practitioners in the field, and supports a holistic data integrity approach using data governance and knowledge management activities.
BETHESDA, Md., Nov. 11, 2020 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) announced the release of its latest Guide, ISPE GAMP® RDI Good Practice Guide: Data Integrity by Design. This Guide was written by a group of experts and reviewed by regulators and practitioners in the field, and supports a holistic data integrity approach using data governance and knowledge management activities.
"Data Integrity by Design is the concept that data integrity must be incorporated from the initial planning of a business process through to the implementation, operation and retirement of computerized systems supporting that business process," said Lorrie Vuolo-Schuessler, Guide Co-Lead, Senior Director Computer Systems Quality and Data Integrity, Syneos Health. "It promotes the application of critical thinking to identify how data flows through the business process and to proactively assess and mitigate risks across both the system and data lifecycles. It emphasizes data integrity as foundational to protecting patient safety and product quality."
This Guide provides a bridge between the system lifecycle approach defined in ISPE GAMP® 5: A Risk-Based Approach to Compliant GxP Computerized Systems, and the data lifecycle approach in the ISPE GAMP® Guide: Records and Data Integrity. Data integrity can only be achieved when both lifecycle approaches are adopted, understood, and actively managed.
Several new areas are covered in this Guide's appendices, including knowledge management, instrument devices and an appendix on Computer Software Assurance (CSA) that details CSA key concepts and provides illustrative case studies.
"Computer Software Assurance was born from US FDA CDRH's Case for Quality which treats compliance attainment as the baseline and promotes the inclusion of critical-to-quality practices that result in improved quality outcomes," said Charlie Wakeham, Guide Co-Lead, APAC GxP Compliance Manager, Waters Corporation. "An industry team was formed, and work begun on the development of an FDA Draft guidance to apply this paradigm to Computerized System Validation (CSV). In an industry first, members of this CSA team have collaborated closely with GAMP subject matter experts to create an appendix to the Data Integrity by Design Guide detailing the key concepts of CSA and providing illustrative case study examples of its application."
"As with all GAMP® Guides, the content has been written by active industry personnel, passionate about patient safety and improvements to the regulated industry, who have experienced the problems, the issues, and the pain in their day jobs," said Jim Henderson, Guide Co-Lead, Business/Computer System QA, Eli Lilly and Company. "This elicits a level of practicality and detail in the guidance that allows the reader to readily apply the guidance to their own organizations."
Get an idea of what this Guide has to offer by viewing the table of contents.
Purchase the ISPE GAMP® RDI Good Practice Guide: Data Integrity by Design online, available at ISPE.org/Publications/Guidance-Documents, among ISPE's other detailed education resources on a variety of industry topics.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. Visit ISPE.org for more information.
For more information, contact:
Amy Henry
Marketing Communications Manager
International Society for Pharmaceutical Engineering (ISPE)
Email: [email protected]
ISPE.org
Media Contact
Amy Henry, ISPE, 8139602105, [email protected]
SOURCE ISPE
Share this article